Emotion-focused therapy and forgiveness in the older population: Protocol for a feasibility randomized controlled trial

Clinical Snapshot

Key Findings

• P Value: Not applicable - protocol stage

• Effect Size: Not applicable - protocol stage

• Primary Outcome: Feasibility (recruitment/retention rates, protocol adherence)

• Nnt Or Sensitivity: Not applicable - feasibility study design

• Confidence Interval: Not applicable - protocol stage

Clinical Application

Limited by requirement for 12 weekly sessions and specialised EFT training Would require adaptation for Australian cultural context; potential Medicare rebates under Better Access scheme if delivered by qualified psychologists Community-dwelling older adults with unresolved interpersonal grievances

Abstract

Over recent decades, Emotion-Focused Therapy, aging, and forgiveness have garnered significant attention in the field of psychology. However, there is a lack of studies on Emotion-Focused Therapy and forgiveness specifically tailored for older adults. This article presents a protocol designed to assess the feasibility and acceptability of a randomized controlled trial of Emotion-Focused Therapy aimed at resolving emotional injuries in individuals aged 65 and older, within the context of interpersonal offenses. Feasibility will be evaluated through recruitment and retention rates, as well as adherence to the intervention protocol. Acceptability will be assessed based on perceived treatment credibility, participants' expectations regarding outcomes, levels of engagement, and overall satisfaction with the intervention. The study is structured as a two-arm, parallel-group randomized trial with a waiting list control. We propose recruiting a sample of 70 participants, randomly assigned to either an immediate intervention group, which will receive Emotion-Focused Therapy over twelve weekly sessions, or a control group that will receive the same therapy after a twelve-week waiting period. Data will be collected in the beginning, middle, and at the end of therapy, and in two planned follow-ups (three and six months after therapy). Once this protocol is implemented, if the therapy proves to be feasible, acceptable, and shows promising results, the findings will inform a large-scale randomized clinical trial to advance the understanding of this treatment for individuals aged 65 + .